Farmakoterapia w Psychiatrii i Neurologii

Full text

2/2020 vol. 36
Case report

New psychopharmacotherapy dilemmas associated with COVID-19 – case report

Jolanta Kucharska-Mazur 1
,
Jędrzej Stańczak 1
,
Jerzy Samochowiec 1
  1. Department of Psychiatry, Pomeranian Medical University in Szczecin
Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (2), 149–153
Data publikacji online: 2021/12/06
Article file
06R_IPiN_FARM_2020-2C.pdf
  1. Arechin, ChPL, http://www.urpl.gov.pl/sites/default/files/Are chin%20Charakterystyka%20Produktu%20Leczniczego.pdf.
  2. Detailed recommendations for interactions with experimen tal COVID-19 therapies. https://www.covid19-druginterac tions.org/, University of Liverpool.
  3. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 as sociated pneumonia in clinical studies. Biosci Trends. 2020 Mar 16; 14(1): 72–73. Doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
  4. Saleh M, Gabriels J, Chang D, Kim BS, Mansoor A, Mahmood E, Makker P, Ismail H, Goldner B, Willner J, Beldner S, Mitra R, John R, Chinitz J, Skipitaris N, Mountantonakis S, Epstein LM. The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection. Circ Arrhythm Electrophysiol. 2020 Apr 29. doi: 10.1161/CIRCEP.120.008662.
  5. Touret F, Lamballerie X. Of chloroquine and COVID-19, Antiviral Res. 2020 May; 177: 104762. Doi: 10.1016/j.anti viral.2020.104762.
  6. Uvais NA. The Risks of Prescribing Hyodroxychloroquine in COVID-19-Infected Patients With Schizophrenia. Prim Care Companion CNS Disord. 2020 Apr 30;22(3). pii: 20com02635. Doi: 10.4088/PCC.20com02635
SUBMIT YOUR PAPER
Share
without publication fees
without publication fees
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications